Several 3D printing technologies are currently considered more clinically applicable, including SSE, fused deposition ...

Following the success of training programmes of public drug testing labs in 10 states in the country, the Indian Pharmacopoeia Commission (IPC) is all set to launch pan-India capacity building ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

The Drugs Consultative Committee (DCC), the advisory committee that advises the Central and State Governments on matters that require uniform implementation of drug laws across the country, has ...

India’s drug regulator has sounded a fresh alarm over toxic solvent contamination in paediatric syrups, prompting urgent ...

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro and in ...

Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...

Sudeep Pharma is set to announce its IPO allotment on Wednesday, with early grey market indications suggesting a potential ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) today announce the U.S. Food and Drug Administration (FDA) has granted accelerated approval of ...

Sudeep Pharma is set to list today after raising Rs 895 crore through a mix of fresh shares and an offer for sale. The grey ...

Sudeep Pharma’s IPO GMP today is ₹ 87. With the issue price of ₹ 593, Sudeep Pharma IPO’s estimated listing price is seen at ...